UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Pseudoephedrine-containing drugs could cause acute skin reaction’
by Lee Hye-seon
2019-01-31 14:34
₩4.7 billion spent on compensation for side effect injuries in 4 years
by Lee Hye-seon
2019-01-30 17:18
Government to tighten rule for drug license renewal
by Lee Hye-seon
2019-01-29 12:51
Korea to set up new review process for advanced medical devices
by Lee Hye-seon
2019-01-28 17:35
4 local firms win exclusive rights to sell Pradaxa’s generic copies
by Lee Hye-seon
2019-01-28 11:56
라인
Two CROs reprimanded for delayed reports of adverse events
by Lee Hye-seon
2019-01-24 15:40
Court rejects patent registration for acute myeloid leukemia drug Vyxeos
by Lee Hye-seon
2019-01-23 14:47
New HIV combo pill Biktarvy approved in Korea
by Lee Hye-seon
2019-01-21 15:36
‘Pharmaceuticals need President Moon’s committed support’
by Lee Hye-seon
2019-01-17 17:39
Intra-articular injection Conjuran recognized as new medical tech
by Lee Hye-seon
2019-01-15 14:07
라인
Baxter’s dialyzer suspended due to bad-mouthing rival products
by Lee Hye-seon
2019-01-15 11:42
5 pharmaceuticals win nod for sustained-release neuropathic pain reliever
by Lee Hye-seon
2019-01-14 14:56
14 drugmakers to release generic copies of Stillen 2X in early February
by Lee Hye-seon
2019-01-14 11:34
Dongkoo to test stem cell therapy for diabetic foot ulcers
by Lee Hye-seon
2019-01-11 15:53
MSD Korea recalls HIV drug Stocrin with particular code
by Lee Hye-seon
2019-01-10 11:46
라인
Regulator keeps Kyung Nam Pharm listed with 1-year grace period
by Lee Hye-seon
2019-01-09 14:49
Handok and Genexine become largest stakeholder of Rezolute
by Lee Hye-seon
2019-01-08 14:53
New influenza drug to be tested in phase-3 trial in Korea
by Lee Hye-seon
2019-01-07 15:30
Regulator to nix approval for Lou Gehrig's drug Yoos Neurosolution
by Lee Hye-seon
2019-01-07 12:46
5 pharmaceuticals’ growth strategies for 2019
by Lee Hye-seon
2019-01-02 16:25
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top